Bernard is a Managing Director in Healthcare Investment Banking at Canaccord Genuity (Australia). He has advised senior management teams and boards for over 15 years on a range of financial and strategic matters, successfully executing over 100 transactions, including US$10 billion in financings and US$80 billion in M&A and advisory activities. Bernard returned to Australia after spending 17 years in New York, US. Prior to joining the Australian team in 2023, Bernard was a Managing Director in Healthcare Investment Banking at Canaccord Genuity (US) for over 5 years and an Executive Director in Healthcare Investment Banking at Oppenheimer & Co (US) for over 7 years. Bernard has a PhD from the University of Adelaide and an MBA from Stern School of Business at New York University.
